Cargando…
Behavioral- and blood-based biomarkers for Huntington's disease: Studies on the R6/1 mouse model with prospects for early diagnosis and monitoring of the disease
BACKGROUND: Huntington's disease (HD) is a genetic neurodegenerative disorder characterized by a triad of cognitive, psychiatric and motor symptoms. One of the main mechanisms of the disease, besides the aggregation of mutant proteins, is the chronic inflammation that occurs in patients long be...
Autores principales: | Podlacha, Magdalena, Pierzynowska, Karolina, Gaffke, Lidia, Jerzemowska, Grażyna, Piotrowska, Ewa, Węgrzyn, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253406/ https://www.ncbi.nlm.nih.gov/pubmed/35799674 http://dx.doi.org/10.1016/j.bbih.2022.100482 |
Ejemplares similares
-
Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies
por: Pierzynowska, Karolina, et al.
Publicado: (2020) -
How close are we to therapies for Sanfilippo disease?
por: Gaffke, Lidia, et al.
Publicado: (2017) -
Genistein induces degradation of mutant huntingtin in fibroblasts from Huntington’s disease patients
por: Pierzynowska, Karolina, et al.
Publicado: (2019) -
Activities of (Poly)phenolic Antioxidants and Other Natural Autophagy Modulators in the Treatment of Sanfilippo Disease: Remarkable Efficacy of Resveratrol in Cellular and Animal Models
por: Rintz, Estera, et al.
Publicado: (2022) -
Mucopolysaccharidosis and Autophagy: Controversies on the Contribution of the Process to the Pathogenesis and Possible Therapeutic Applications
por: Pierzynowska, Karolina, et al.
Publicado: (2019)